NEW YORK (GenomeWeb) – Children's Hospital Colorado and SomaLogic today announced a collaboration aimed at the discovery of protein biomarkers for diagnosing and managing childhood diseases.

Using SomaLogic's SomaScan assay, which measures more than 1,000 proteins from a patient's sample, researchers will analyze proteins from blood samples obtained from children suffering from diseases, and then select those proteins that are correlated with particular diseases and their severity to potentially develop laboratory tests for clinical use.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.